Arsenic, lead and other metals in tampons aren’t harmful, FDA report concludes
FDA report finds metals in tampons not harmful
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A recent FDA report concludes that the presence of arsenic, lead, and other metals in tampons is not a cause for concern.
The report's findings are emphasized in coverage from various outlets, including Bloomberg.com, The Straits Times, and NBC News. These sources highlight that the levels of metals in tampons are too low to harm users.
According to the FDA's bench study, the metal levels in tampons do not pose a risk to users. The FDA has published information on menstrual product options, facts, and safe use on its website fda.gov.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. Updated just now.
Quick answers
What did the FDA report conclude about metals in tampons?
The FDA report concluded that the presence of arsenic, lead, and other metals in tampons is not a cause for concern.
Which outlets covered the FDA report?
Bloomberg.com, The Straits Times, insights.citeline.com, fda.gov, and NBC News covered the report.
Where can I find information on menstrual product options and safe use?
The FDA has published information on menstrual product options, facts, and safe use on its website fda.gov.
Coverage (5)
- Heavy Metals in Tampons Aren’t Cause for Concern, Regulators Say Bloomberg.com · 6h ago
- Heavy metals in tampons aren’t cause for concern, US regulators say The Straits Times · 6h ago
- FDA Bench Study Finds Tampon Metal Levels Too Low To Harm Users insights.citeline.com · 6h ago
- Menstrual Product Options, Facts, and Safe Use fda.gov · 6h ago
- Arsenic, lead and other metals in tampons aren’t harmful, FDA report concludes NBC News · 6h ago broke it first
People, places & organizations
Topics
Related trends
FDA approves Vera Therapeutics kidney disease treatment
The FDA has approved Vera Therapeutics' drug Trutakna to treat primary IgA nephropathy, sparking a new market competition for kidney disease treatments.
Publix recalls blueberries after multiple people reportedly became severely sick with E. coli. Here are the impacted states
Publix is recalling frozen blueberries across eight states following 12 reports of E. coli contamination.
Tobacco Companies Are Cashing In on Zyn’s Unstoppable Popularity
Tobacco companies are racing to capitalize on the surging popularity of Zyn and other smoke-free alternatives.
The New Rules of Sunscreen
The U.S. sunscreen market is shifting toward clinical necessity following the FDA's first approval of a new active ingredient in decades.
Potato chip recall upgraded to highest FDA risk level over salmonella concerns
The FDA has upgraded a potato chip recall involving brands like Utz Zapp's and Dirty to Class I, its highest risk level, due to salmonella concerns.
Exclusive: FDA allows ZYN to sell pouches on health benefits
The FDA has granted Philip Morris permission to market ZYN nicotine pouches as a safer, lower-risk alternative to cigarettes.